Hologic SEC Filings

Type
Report
Date
4Insidertransaktion3/2/2026
4Insidertransaktion3/2/2026
4Insidertransaktion3/2/2026
4Insidertransaktion3/2/2026
4Insidertransaktion3/2/2026
4Insidertransaktion3/2/2026
4Insidertransaktion3/2/2026
4Insidertransaktion3/2/2026
4Insidertransaktion3/2/2026
SCHEDULE 13G/ASCHEDULE 13G/A-Formular2/17/2026
4Insidertransaktion2/12/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/6/2026
4/A4/A-Formular2/3/2026
4Insidertransaktion2/3/2026
DEFA14ADEFA14A-Formular1/29/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/29/2026
10-QQuartalsbericht1/29/2026
DEFA14ADEFA14A-Formular1/26/2026
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/26/2026
10-K/A10-K/A-Formular1/22/2026
DEFA14ADEFA14A-Formular1/12/2026
DEFM14ADEFM14A-Formular12/23/2025
4Insidertransaktion12/16/2025
PREM14APREM14A-Formular12/12/2025
4Insidertransaktion11/18/2025
4Insidertransaktion11/18/2025
4Insidertransaktion11/18/2025
4Insidertransaktion11/18/2025
10-KJahresbericht11/18/2025
4Insidertransaktion11/18/2025
4Insidertransaktion11/18/2025
4Insidertransaktion11/18/2025
4Insidertransaktion11/18/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular11/14/2025
4Insidertransaktion11/12/2025
4Insidertransaktion11/12/2025
4Insidertransaktion11/12/2025
4Insidertransaktion11/12/2025
4Insidertransaktion11/12/2025
4Insidertransaktion11/12/2025
4Insidertransaktion11/12/2025
4Insidertransaktion11/12/2025
4Insidertransaktion11/12/2025
DEFA14ADEFA14A-Formular11/10/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/7/2025
4Insidertransaktion11/6/2025
4Insidertransaktion11/6/2025
4Insidertransaktion11/6/2025
4Insidertransaktion11/6/2025
4Insidertransaktion11/6/2025
4Insidertransaktion11/6/2025
DEFA14ADEFA14A-Formular11/5/2025
DEFA14ADEFA14A-Formular11/3/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben11/3/2025
DEFA14ADEFA14A-Formular10/28/2025
4Insidertransaktion10/22/2025
DEFA14ADEFA14A-Formular10/21/2025
DEFA14ADEFA14A-Formular10/21/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben10/21/2025
DEFA14ADEFA14A-Formular10/21/2025
DEFA14ADEFA14A-Formular10/21/2025
144144-Formular10/20/2025
4Insidertransaktion9/23/2025
144144-Formular9/22/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben9/19/2025
10-QQuartalsbericht7/31/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/30/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben7/18/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular7/8/2025
4Insidertransaktion6/3/2025
SDSD-Formular5/23/2025
4Insidertransaktion5/9/2025
10-QQuartalsbericht5/2/2025
33-Formular5/2/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben5/1/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular4/17/2025
4Insidertransaktion4/9/2025
33-Formular4/9/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben4/4/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben3/3/2025
4Insidertransaktion2/28/2025
4Insidertransaktion2/28/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/28/2025
4Insidertransaktion2/28/2025
4Insidertransaktion2/28/2025
4Insidertransaktion2/28/2025
4Insidertransaktion2/28/2025
4Insidertransaktion2/28/2025
SCHEDULE 13G/ASCHEDULE 13G/A-Formular2/14/2025
4Insidertransaktion2/12/2025
10-QQuartalsbericht2/6/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben2/5/2025
33-Formular1/24/2025
DEF 14ADEF 14A-Formular1/16/2025
ARSARS-Formular1/16/2025
DEFA14ADEFA14A-Formular1/16/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/13/2025
8-KAllgemeines, mitteilungspflichtiges Informationsschreiben1/10/2025
4Insidertransaktion12/17/2024
4Insidertransaktion12/11/2024

Hologic Documents 2026

This page contains all official documents and SEC filings for Hologic stock (HOLX, ISIN: US4364401012). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 100 documents are available. Data is updated regularly to provide investors with a complete overview of Hologic's regulatory filings.

Hologic Stock analysis

Hologic Hologic Inc. is a company from the United States that has established itself in the medical technology market. The company was founded in 1985 by Jay A. Stein, who set the goal of developing products and services that contribute to improving people's lives. Hologic specializes in artificial intelligence (AI) based diagnostic and therapeutic technology that increases the safety, effectiveness, and accuracy of medical procedures. The company initially focused on products in the field of mammography, but has since expanded to various sectors including imaging, gynecology, skeletal, and surgery. Hologic offers its customers products such as tomosynthesis systems, robot-assisted surgery systems, image analysis software, and a variety of reagents, kits, and tests. The company's business model is focused on innovative technology and science, aiming to optimize medical interventions and thus reduce and improve healthcare costs. Hologic is dedicated to research and development and has already filed dozens of patents. In the field of breast cancer diagnostics, Hologic has developed various mammography systems that have broken the standard of mammography. Through the use of tomosynthesis, a 3D-based diagnostic, it is possible to detect tumors and malignant changes earlier. This procedure has been widely used by many doctors around the world and has proven to be a reliable method for early detection of breast cancer. In gynecology, Hologic specializes in the development of diagnostic tests for infectious agents and hormones. The tests, such as the Aptima HPV test, are fast, sensitive, and reliable. They help to detect infectious agents earlier and initiate appropriate therapy. Hologic Taurus, a robot-assisted surgery system, has been developed to enable minimally invasive interventions that can be used to treat uterine fibroids. This method allows for a drastic reduction in hospital stay duration and recovery time. In the field of skeletal, Hologic offers various systems that are helpful in the diagnosis and treatment of osteoporosis. The widely used DXA system (Dual-Energy X-Ray Absorptiometer) is still one of the most accurate devices for measuring bone density. Additionally, Hologic is an company that not only focuses on medical technology but also pursues the larger goal of improving people's lives. An example of this is their partnership with the organization Pink Ribbon, which serves as a global ambassador for breast cancer early detection. Hologic has developed a special mammography system called Pink Affirm. For every system sold, Hologic donates a certain amount to Pink Ribbon. Overall, Hologic Inc. has become an important player in the field of medical technology and diagnostics. Through its innovative technologies and products, the company contributes to improving the health and lives of people worldwide.